• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FLGC

    Flora Growth Corp.

    Subscribe to $FLGC
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis oil extracts and related products; manufactures and sells skincare and beauty products, such as gel cleanser, eye cream, moisturizer, and hydrating mask; manufactures dermo cosmetic products; and develops and sells pharmaceutical and over-the-counter products, including dietary supplements, phytotherapeutic and nutraceutical products, supplements, and related products. It also manufactures and sells hemp textiles products focuses on servicing the hospitality, medical, and clothing industries on a B2B basis; designs, produces, and supplies juices, chocolate, and chocolate related products to wholesale distributors, pharmacies, supermarkets, and online distributors; and offers and wellness products. The company's brand includes Mambe, Mind Naturals, Almost Virgin, Flora Lab, and Stardog Loungewear. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: floragrowth.ca

    Recent Analyst Ratings for Flora Growth Corp.

    DatePrice TargetRatingAnalyst
    11/25/2024$4.00Buy
    Aegis Capital
    10/13/2021$10.00Buy
    Roth Capital
    6/23/2021$6.00Buy
    MKM Partners
    See more ratings

    Flora Growth Corp. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/17/24 10:17:39 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/11/24 5:43:51 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Starke Clifford bought $48 worth of shares (51 units at $0.95), increasing direct ownership by 0.01% to 474,046 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/6/24 5:25:10 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Starke Clifford bought $999,998 worth of shares (526,315 units at $1.90) (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      4/9/24 2:17:36 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woo Edward was granted 50,000 shares, increasing direct ownership by 59% to 134,698 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:22:07 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Wolkin Harold

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:19:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by CFO Vaiman Dany

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:01:07 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Starke Clifford was granted 900,000 shares, increasing direct ownership by 13,146% to 906,846 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 9:58:52 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Leventhal Manfred

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 9:56:43 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Executive Chairman Dorf Sammy was granted 250,000 shares (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 9:54:01 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by new insider Leventhal Manfred

      3 - Flora Growth Corp. (0001790169) (Issuer)

      12/16/24 5:11:24 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by new insider Dorf Sammy

      3 - Flora Growth Corp. (0001790169) (Issuer)

      12/13/24 3:32:27 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/17/24 10:17:39 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/11/24 5:43:51 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. SEC Filings

    See more
    • SEC Form S-3 filed by Flora Growth Corp.

      S-3 - Flora Growth Corp. (0001790169) (Filer)

      5/14/25 4:02:08 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Flora Growth Corp.

      10-Q - Flora Growth Corp. (0001790169) (Filer)

      5/13/25 4:56:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form D filed by Flora Growth Corp.

      D - Flora Growth Corp. (0001790169) (Filer)

      5/8/25 7:36:37 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form DEF 14A filed by Flora Growth Corp.

      DEF 14A - Flora Growth Corp. (0001790169) (Filer)

      5/5/25 7:50:59 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SCHEDULE 13G filed by Flora Growth Corp.

      SCHEDULE 13G - Flora Growth Corp. (0001790169) (Subject)

      5/2/25 4:10:49 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Flora Growth Corp. (0001790169) (Filer)

      5/2/25 4:06:04 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Flora Growth Corp.

      SCHEDULE 13G/A - Flora Growth Corp. (0001790169) (Subject)

      4/29/25 9:00:12 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form PRE 14A filed by Flora Growth Corp.

      PRE 14A - Flora Growth Corp. (0001790169) (Filer)

      4/15/25 4:01:21 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Flora Growth Corp.

      EFFECT - Flora Growth Corp. (0001790169) (Filer)

      3/31/25 12:15:23 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form S-3/A filed by Flora Growth Corp.

      S-3/A - Flora Growth Corp. (0001790169) (Filer)

      3/25/25 8:07:29 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      12/17/24 8:02:53 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      12/17/24 8:01:40 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Flora Growth Corp.

      SC 13G/A - Flora Growth Corp. (0001790169) (Subject)

      11/14/24 2:24:54 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D filed by Flora Growth Corp.

      SC 13D - Flora Growth Corp. (0001790169) (Subject)

      9/12/24 5:24:51 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      9/11/24 1:43:04 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Flora Growth Corp.

      SC 13G - Flora Growth Corp. (0001790169) (Subject)

      6/27/24 5:15:12 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by Flora Growth Corp. (Amendment)

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      4/15/24 2:45:02 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Flora Growth Corp.

      SC 13G - Flora Growth Corp. (0001790169) (Subject)

      2/14/24 3:12:42 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Flora Growth Corp.

      SC 13G - Flora Growth Corp. (0001790169) (Subject)

      12/8/23 5:22:27 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by Flora Growth Corp. (Amendment)

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      11/15/23 5:27:44 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Flora Growth Corp. Closes Acquisition of Australian Vaporizers

      Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, 2024. Australian Vaporizers was founded in 2010 and has become one of the largest online retailers of vaporizers, hardware, and accessories in Australia. It is an online expert for aromathe

      6/5/24 9:20:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lifeist Sells Australian Vapes

      TORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. ("Aussie Vapes"), its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC) ("Flora"), a U.S.-based consumer-packaged goods and pharmaceutical distributor serving all 50 states and 28 countries. The sale was completed through a share purchase agreement (the "SPA") entered into between Lifeist, as vendor, and Flora Growth Corp, as purchaser, purs

      6/5/24 7:00:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • TSX Venture Exchange Stock Maintenance Bulletins

      VANCOUVER, BC, June 4, 2024 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2024-1678 CEAPRO INC. ("CZO")BULLETIN TYPE: Plan of Arrangement, Remain Halted, DelistBULLETIN DATE: June 4, 2024TSX Venture Tier 2 Company  TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholder

      6/4/24 11:24:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. Forms Joint Venture with Althea Group Holdings to Create Leading Beverages Brand in U.S. Market

      Flora and Althea have established Peak USA JV LLC ("Peak USA") - a 50/50 joint venture aiming to capitalize on the beverages market. Each party to the joint venture contributed $250,000 of operating capital. Peak USA will link Flora's U.S.-based CPG team with Althea's Peak Processing Solutions ("Peak"), which is a recognized market leader in cannabis-infused beverages. Peak has a 40% market share in Canada. Peak USA will combine Flora's brand-launching expertise with Althea's processing experience to produce the next generation of beverages for the U.S. market. According to Headset Data, the beverage market segment currently represents only 1% to 3% of the U.S. cannabis market. First-time da

      6/4/24 9:20:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Vessel Brand Unveils the Second-Generation Compass Rise - The Next Evolution in Functionality and Elegance

      Fort Lauderdale, Florida--(Newsfile Corp. - May 30, 2024) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company")'s Vessel Brand ("Vessel"), renowned for its design and precision craftsmanship, proudly announces the release of Compass Rise. Built for the discerning connoisseur, Compass Rise embodies sophistication while delivering what consumers have come to expect from Vessel's products. From its sleek design, cutting-edge technology, and the ability to stay upright, every aspect of Compass Rise reflects Vessel's dedication to meeting changing market trends. "Building on the continued success of Compass, our one-of-a-kind, compact, high-powered vape device, we are excited to introduce

      5/30/24 9:20:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Aegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC)

      NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC).About Flora Growth Corp.Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, pe

      4/9/24 10:45:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lifeist Terminates Agreement for Sale of Australian Vapes

      TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness announces the termination of the share purchase agreement (the "SPA") entered into on September 17, 2023 with Flora Growth Corp. (NASDAQ:FLGC) ("Flora") to divest and sell Australian Vaporizers Pty Limited ("Australian Vapes"), its wholly owned Australian subsidiary, to Flora. The transaction and its details were previously disclosed in a news release dated September 18, 2023, a copy of which can be found on SEDAR+ under

      10/24/23 10:44:35 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lifeist Announces Sale of Non-core Subsidiary Australian Vapes

      TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced it has entered into a definitive share purchase agreement (the "SPA") with Flora Growth Corp. (NASDAQ:FLGC) ("Flora") to divest and sell Australian Vaporizers Pty Limited ("Australian Vapes"), its wholly owned Australian subsidiary, to Flora for a purchase price of US$1.9 million, subject to certain adjustments. The transaction is expected to close in late September or early in the fourth quarter of 202

      9/18/23 7:00:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement

      Fort Lauderdale, Florida--(Newsfile Corp. - June 27, 2023) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead its global operations and Dany Vaiman has been appointed as Chief Financial Officer. Mr. Starke, who previously served as President of the Company, takes over for Hussein Rakine, who resigned as CEO but will remain on the Company's Board of Directors. Mr. Rakine expressed his confidence in the appointment, stating, "Clifford's

      6/27/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. to Effect Reverse Stock Split

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a global cultivator, manufacturer, and distributor of cannabis products and brands, announces that it will effect a reverse stock split, which shall become effective on June 9, 2023 at a ratio of 1-for-20 (the "Reverse Stock Split"). The Company has provided The Nasdaq Stock Market with the appropriate notice and the Company expects that its common shares will commence trading on a post-Reverse Stock Split basis at market open on June 9, 2023. The common shares will continue to trade on the Nasdaq Capital Market under the existing ticker "FLGC". The new CUSIP number for the common shares is 339764201 and the new ISIN is CA339764

      6/7/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Leadership Updates

    Live Leadership Updates

    See more
    • Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement

      Fort Lauderdale, Florida--(Newsfile Corp. - June 27, 2023) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead its global operations and Dany Vaiman has been appointed as Chief Financial Officer. Mr. Starke, who previously served as President of the Company, takes over for Hussein Rakine, who resigned as CEO but will remain on the Company's Board of Directors. Mr. Rakine expressed his confidence in the appointment, stating, "Clifford's

      6/27/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the "Board") accepted the resignation of Luis Merchan as Chairman of the Board and the Company's Chief Executive Officer (CEO). To fill the vacancies created by Mr. Merchan's resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors. Of the appointment, former-Chairman and CEO, Luis Merchan said, "At Flora we have consistently placed human capital as a critical part of our M&A strategy. That's why today we are honored to have the former foun

      4/18/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CBD Oil Market to Hit Nearly US$137 Billion by 2029

      FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Aug. 23, 2022 /PRNewswire/ -- The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare products, increased use of THC and CBD in pain management and treatment, rising sales in both retail stores and online, expanding research, and increasing demand for ingestible products. Governments around the world have also begun opening up more doors for CBD, with a recent Health Canada report suggesting legal framework to broaden retail CBD sales across

      8/23/22 8:50:00 AM ET
      $CGC
      $CRON
      $FLGC
      $OGI
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Flora Growth Taps Amazon Executive Elshad Garayev As Chief Financial Officer

      Former Amazon financial operations excellence leader and leading e-commerce platform strategist to assist Flora with financial discipline and reporting Garayev brings 25 years of financial leadership experience at Amazon, Boeing, BP and RPK Capital, and will focus on Flora's global growth initiatives Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today the appointment of Elshad Garayev to serve as Flora's Chief Financial Officer, effective on the business day following the date on which the Company files its mid-year financial results with the Securities and Ex

      7/11/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Announces Results of Annual Meeting of Shareholders; Appointment of Brandon Konigsberg to Board of Directors

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that at the Company's annual meeting of shareholders held on July 5, 2022, the Company's shareholders voted in favor of all of the proposals submitted for their approval. The four proposals that were approved included (i) the election of seven members to the Company's Board of Directors (the "Board"), (ii) the re-appointment of Davidson & Company LLP as the Company's auditors, (iii) the approval of the Company's 2022 Incentive Compensation Plan and (iv) the approval of new bylaw 1-A. For the complete voting result

      7/6/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Appoints Cannabis Regulatory Veteran Holly Bell as Vice President of Regulatory Affairs

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today the appointment of regulatory veteran Holly Bell as Vice President of Regulatory Affairs. Bell will play a critical role in Flora's domestic and global expansion strategy and lead government relations in key international markets. Most recently, Bell was the Florida Department of Agriculture and Consumer Services' first Director of Cannabis. This agency allowed for the creation of manufacturing, cultivation and sales programs in the state. As the Director of Cannabis, Bell worked with leading regulators throughou

      5/16/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Appoints Former Amazon Executive Tim Leslie to Its Board of Directors and Names CEO Luis Merchan Chairman

      Flora Growth's CEO Luis Merchan is named Chairman of the Board of Directors. Tim Leslie, Chairman of Flora's Advisory Board, will join the Flora Board of Directors and audit committee. Changes to the Board of Directors signal the Company's move toward becoming a U.S.-based issuer and will support Flora's growth into new international markets. Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today changes to its Board of Directors (the "Board") including the appointment of CEO Luis Merchan as Chairman of the Board as well as the addition of industry veteran Tim Leslie to the

      3/17/22 8:00:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Appoints Jessie Casner As Chief Marketing Officer to Drive Growth of Brand Portfolio

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, continues to strengthen its executive bench with the appointment of Jessie Casner as Chief Marketing Officer. Ms.Casner joins the Company from the recently acquired Vessel brand, where she was Vice President of Sales and Marketing. The appointment of this position continues to strengthen Flora's executive bench and leadership within the organization. Ms.Casner's experience in brand marketing will support the rapid growth of Flora's core CPG brands, including Vessel, Tonino Lamborghini, Mind Naturals, Stardog, among others. "I'm excited to w

      2/25/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Appoints Award-Winning Operations Expert Joël Reyes as SVP of Global Operations

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of operations and personnel development expert, Joël Reyes as Senior Vice President of Global Operations. Mr. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. Mr. Reyes is charged with implementing operational excellence across the organization, beginning with Flora's robust Columbian activities, including the optimization of Flor

      1/27/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Appoints Industry-Leading Cultivator Derek Pedro as Genetics and Cultivation Advisor

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of world-renowned cannabis genetics and cultivation expert Derek Pedro as an advisor to its Cosechemos cultivation facility. Mr. Pedro brings extensive experience as a cannabis industry pioneer, having consulted on cannabis genetics and cultivation in Canada, the US, Latin America, Europe and China. Mr. Pedro will build upon Flora's existing register of high-THC and high-CBD strains to bring to market uniquely Colombian cannabis flower to both domestic and international markets. The establishment of the genet

      1/24/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegis Capital initiated coverage on Flora Growth with a new price target

      Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00

      11/25/24 8:07:10 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Roth Capital initiated coverage on Flora Growth with a new price target

      Roth Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $10.00

      10/13/21 9:00:51 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • MKM Partners initiated coverage on Flora Growth with a new price target

      MKM Partners initiated coverage of Flora Growth with a rating of Buy and set a new price target of $6.00

      6/23/21 5:36:01 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Flora Growth Corp. Financials

    Live finance-specific insights

    See more
    • Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET. During the webcast, Flora management will deliver financial and operational results for the third quarter ended September 30, 2022, and provide updates on Flora's commercial wholesale operations, house of brands and life sciences division strategies. Following the webcast, Flora management will open the call to analysts, media and investors in a Q&A format. Live Webcast Details Date: Monday, November 28, 2022 Time: 4:30 p.m. ET

      11/21/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that the Company will be hosting an analyst call on Wednesday, October 26, 2022, at 02:00 p.m. EST via webcast to discuss Flora Growth's recent M&A activity and strategic growth opportunities. The conference call and live webcast will invite analysts to pose questions to Flora and Franchise Global Health's leadership teams regarding the recent announcement of the definitive agreement of acquisition between the two companies and the opportunities within the cannabis industry on the global stage. To access this ca

      10/25/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the Company received the Best M&A Deal award at Benzinga's 2022 Cannabis Capital Conference in Chicago. "We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers," said Luis Merchan, Chairman and CEO of Flora. Flora completed the acquisition of JustCBD in February 2022, and it immediately offered the Company an established CPG brand with a por

      9/13/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Acquires No Cap Hemp Co., Bolstering Product Offering And Revenue Streams

      No Cap Hemp Co., an emerging brand in the hemp flower market, will diversify Flora's brand portfolio and product offerings The acquisition provides the opportunity to expand Flora's distribution foothold in the US market, with a unique collection of products with strong revenue growth potential Deal offers Flora an immediate revenue stream and enhances manufacturing capabilities Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that its wholly-owned subsidiary, Just Brands LLC, has acquired substantially all of the assets pertaining to the brand No Cap Hemp Co. (

      9/7/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Reports H1 2022 Financial Results

      H1 2022 revenue increased to ~$15.0 million, up 604% from H1 2021 and 117% from H2 2021, driven by House of Brands Gross Profit increased to ~$7.0 million, up 547% compared to H1 2021 and 363% compared to H2 2021 Company reaffirms its 2022 revenue guidance to range between $35.0 million - $45.0 million, indicating approximately 300% - 400% projected revenue growth from 2021 Management to host a webcast today at 4:30 P.M. ET Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a manufacturer and distributor of global cannabis products and brands, reported today its financial and operating results for the six months ended June 30, 2022. All financial information is provided i

      8/15/22 4:00:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Sets First Half 2022 Conference Call for August 15, 2022, at 4:30 p.m. ET

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its first half 2022 earnings call via webcast on Monday, August 15, 2022, at 4:30 p.m. ET. The Company's results will be reported in a press release prior to the call. During the webcast, Flora management will deliver financial and operational results for the six months ended June 30, 2022, in addition to comments on the Company's 2022 commercial operations, house of brands and life sciences strategies. Following the presentation, Flora will open the floor to analysts, media and investors in a Q&A format. Live Audio W

      8/10/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Acquires CBD Brand Masaya

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that it has entered into an agreement with leading cell biologist, Dr. Annabelle Manalo-Morgan, Ph.D., to acquire her brand Masaya, together with its patent-pending CBD formulations. Created by Dr. Annabelle and backed by her research, Masaya's formulations of pure, potent CBD oil are 100% THC-free and have a long track record of positive testimonials collected over years of use. Flora intends to distribute the brand and its formulations worldwide. Masaya will become an owned Flora brand sold in the US and will b

      5/23/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Announces Unaudited Financial Results for the Six Month Period Ended June 30, 2021

      Flora Growth Corp. ("Flora" or the "Company') (NASDAQ:FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today announced its financial results for the six month period ended June 30, 2021 (the "Interim Financials"). The Interim Financials, which have not been audited or reviewed by the Company's independent registered accounting firm, have been filed on a Form 6-K with the Securities and Exchange Commission today. The operational highlights of the Interim Financials are included below. Six Month Period Ended June 30, 2021 Operational Highlights Revenue: $2.1M Operating Expenses: $7.2M Cash Balance: $18.8M Net L

      9/17/21 4:10:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth to Hold First Half 2021 Earnings Call on August 19, 2021 After Market Close

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will host its first half 2021 earnings call via webcast on Thursday, August 19th, 2021 at 4:30 p.m. ET following the release of its first half 2021 financial results. During the webcast, management will deliver financial results, operational updates, and provide comments on recent growth and M&A initiatives announced in the period since the Company listed its shares on the Nasdaq Capital Market on May 11th, 2021. Following the presentation, Flora will offer analysts, media, and investors the opportunity to ask questions in a question-and-ans

      8/6/21 2:30:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care